Nektar Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results

SAN FRANCISCO , Feb. 25, 2021 /PRNewswire/ —  Nektar Therapeutics  (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, 2020.     Cash and investments in marketable securities at December 31, 2020 were approximately $1.2 billion as compared


Get every new post delivered right to your inbox.

Original Source